Journal of Embryo Transfer (한국수정란이식학회지)

The Korean Society of Embryo Transfer (한국수정란이식학회)
권호 표지

Functional Expression of the Internal Rotenone-Insensitive NADH-Quinone Oxidoreductase (NDI1) Gene of Saccharomyces cerevisiae in Human HeLa Cells

  • Seo, Byoung-Boo (Division of Biochemistry, the Department of Molecular and Experimental Medicine, The Scripps Research Institute)
  • Received : 2010.02.25
  • Accepted : 2010.03.09
  • Published : 2010.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Many studies propose that dysfunction of mitochondrial proton-translocating NADH-ubiquinone oxidoreductase (complex I) is associated with neurodegenerative disorders, such as Parkinson's disease and Huntington's disease. Mammalian mitochondrial proton-translocating NADH-quinone oxidoreductase (complex I) consists of at least 46 different subunits. In contrast, the NDI1 gene of Saccharomyces cerevisiae is a single subunit rotenone-insensitive NADH-quinone oxidoreductase that is located on the matrix side of the inner mitochondrial membrane. With a recombinant adeno-associated virus vector carrying the NDI1 gene (rAAV-NDI1) as the gene delivery method, we were able to attain high transduction efficiencies even in the human epithelial cervical cancer cells that are difficult to transfect by lipofection or calcium phosphate precipitation methods. Using a rAAV-NDI1, we demonstrated that the Ndi1 enzyme is successfully expressed in HeLa cells. The expressed Ndi1 enzyme was recognized to be localized in mitochondria by confocal immunofluorescence microscopic analyses and immunoblotting. Using digitonin-permeabilized cells, it was shown that the NADH oxidase activity of the NDI1-transduced HeLa cells were not affected by rotenone which is inhibitor of complex I, but was inhibited by flavone and antimycin A. The NDI1-transduced cells were able to grow in media containing rotenone. In contrast, control cells that did not receive the NDI1 gene failed to survive. In particular, in the NDI1-transduced cells, the yeast enzyme becomes integrated into the human respiratory chain. It is concluded that the NDI1 gene provides a potentially useful tool for gene therapy of mitochondrial diseases caused by complex I deficiency.

Keywords

References

  1. Bai Y, Hajek P, Chomyn A, Chan E, Seo BB, Matsuno-Yagi A, Yagi T and Attardi G. 2001. Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDII) gene. J. BioI. Chem. 276:38808-38813. https://doi.org/10.1074/jbc.M106363200
  2. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV and Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301-1306. https://doi.org/10.1038/81834
  3. Buchanan SK and Walker JE. 1996. Large-scale chromatographic purification of F1F0-ATPase and complex I from bovine heart mitochondria. Biochem. J. 318:343-349.
  4. Chomyn A, Cleeter MWJ, Ragan CI, Riley M, Doolittle RF and Attardi G. 1986. URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science 234:614-618. https://doi.org/10.1126/science.3764430
  5. Chomyn A, Mariottini P, Cleeter MWJ, Ragan CI, MatsunoYagi A, Hatefi Y, Doolittle RF and Attardi G. 1985. Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 314:591-597.
  6. Dawson TM and Dawson VL. 2003. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819- 822. https://doi.org/10.1126/science.1087753
  7. de Vries Sand Grivell LA. 1988 Purification and characterization of a rotenone-insensitive NADH-Q6 oxidoreductase from mitochondria of Saccharomyces cerevisiae. Eur. J. Biochem. 176:377-384. https://doi.org/10.1111/j.1432-1033.1988.tb14292.x
  8. de Vries S, Van Witzenburg R, Grivell LA and Marres CAM. 1992. Primary structure and import pathway of the rotenone- insensitive NADH-ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Eur. J. Biochem. 203:587-592. https://doi.org/10.1111/j.1432-1033.1992.tb16587.x
  9. Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB and Carter BJ. 1993. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90:10613-10617. https://doi.org/10.1073/pnas.90.22.10613
  10. Granger DL and Lehninger AL. 1982. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J. Cell. BioI. 95:527-535. https://doi.org/10.1083/jcb.95.2.527
  11. Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V, Martinuzzi A, Hauswirth WW and Lewin AS. 2002. Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann. Neurol. 52:534-542. https://doi.org/10.1002/ana.10354
  12. Hayashi JI, Ohta S, Kikuchi A, Takemitsu M, Goto YI and Nonaka I. 1991. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc. Natl. Acad. Sci. USA 88:10614-10618. https://doi.org/10.1073/pnas.88.23.10614
  13. Hofhaus G, Shakeley RM and Attardi G. 1996. Use of polarography to detect respiration defects in cell cultures. Methods EnzymoI. 264:476-483. https://doi.org/10.1016/S0076-6879(96)64043-9
  14. Kitajima-Ihara T and Yagi T. 1998. Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria: the enzyme expressed in Escherichia coli acts as a member of the respiratory chain in the host cells. FEBS Lett. 421:37-40. https://doi.org/10.1016/S0014-5793(97)01533-0
  15. Klimatcheva E, Rosenblatt JD and Planelles V. 1999. Lentiviral vectors and gene therapy. Front. Biosci. 4:D481-D496. https://doi.org/10.2741/Klimatcheva
  16. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680- 685. https://doi.org/10.1038/227680a0
  17. Manfredi G, Fu J, Ojaimi J, Sadlock JE, Kwong JQ, Guy J and Schon EA. 2002. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat. Genet. 30:394-399. https://doi.org/10.1038/ng851
  18. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL and Di Monte DA. 2002. The herbicide paraquat causes up-regulation and aggregation of $\alpha$-synuclein in mice: paraquat and $\alpha$-synuclein. J. BioI. Chem. 277:1641-1644. https://doi.org/10.1074/jbc.C100560200
  19. Marres, CAM, de Vries Sand Grivell LA. 1991. Isolation and inactivation of the nuclear gene encoding the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Eur. J. Biochem. 195:857-862. https://doi.org/10.1111/j.1432-1033.1991.tb15775.x
  20. Muzyczka N. 1994. Adeno-associated virus (AAV) vectors: will they work? J. Clin. Invest. 94: 1351. https://doi.org/10.1172/JCI117468
  21. Naldini L, Blomer U, GaUay P, Ory D, Mulligan R, Gage FH, Verma IM and Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267. https://doi.org/10.1126/science.272.5259.263
  22. Owen R, Lewin AP, Peel A, Wang J, Guy J, Hauswirth WW, Stacpoole PW and Flotte TR. 2000. Recombinant adenoassociated virus vector-based gene transfer for defects in oxidative metabolism. Hum. Gene Ther. 11 :2067-2078. https://doi.org/10.1089/104303400750001381
  23. Robbins PD and Ghivizzani SC, 1998. Viral vectors for gene therapy. Pharmacol. Ther. 80:35-47. https://doi.org/10.1016/S0163-7258(98)00020-5
  24. Robinson BH. 1998. Human complex I deficiency: Clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim. Biophys. Acta. 1364: 271-286. https://doi.org/10.1016/S0005-2728(98)00033-4
  25. Schapira AHV, Cooper JM and Morgan-Hughes JA. 1988. Molecular basis of mitochondrial myopathies: Polypeptide analysis in complex I deficiency. Lancet 331 :500-503. https://doi.org/10.1016/S0140-6736(88)91296-2
  26. Seo BB, Kitajima-Ihara T, Chan EK, Scheffler IE, MatsunoYagi A and Yagi T. 1998. Molecular remedy of complex I defects: Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc. Natl. Acad. Sci. USA 95:9167-9171. https://doi.org/10.1073/pnas.95.16.9167
  27. Seo BB, Wang J, Flotte TR, Yagi T, Matsuno-Yagi A (2000) Use of the NADH-quinone oxidoreductase (NDIl) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells. J BioI Chem 275:37774-37778. https://doi.org/10.1074/jbc.M007033200
  28. Seo BB, Matsuno-Yagi A and Yagi T. 1999. Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADHquinone oxidoreductase (NDIl) gene of Saccharomyces cerevisiae. Biochim. Biophys. Acta. 1412:56-65. https://doi.org/10.1016/S0005-2728(99)00051-1
  29. Sherer TB, Betarbet R and Greenamyre JT. 2002. Environment, mitochondria, and Parkinson's disease. Neuroscientist 8:192-197.
  30. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A and Greenamyre JT. 2003. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23:10756-10764.
  31. Shoffner JM and Wallace DC. 1994. Oxidative phosphorylation diseases and mitochondrial DNA mutations diagnosis and treatment. Rev. Nutr. 14:535-568.
  32. Singer DR, Sagnella GA, Markandu ND, Buckley MG and MacGregor GA. 1987. Atrial natriuretic peptide, blood pressure, and age. Lancet 2:1394-1395.
  33. Snyder RO. 1999. Adeno-associated virus-mediated gene delivery. J. Gene. Med. 1:166-175. https://doi.org/10.1002/(SICI)1521-2254(199905/06)1:3<166::AID-JGM34>3.0.CO;2-Z
  34. Todd S, Anderson C, Jolly DJ and Craik CS. 2000. HIV protease as a target for retrovirus vector-mediated gene therapy. Biochim. Biophys. Acta. 1477:168-188. https://doi.org/10.1016/S0167-4838(99)00272-1
  35. Trounce lA, Kim YL, Jun AS and Wallace DC. 1996. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, Iymphoblasts, and transmitochondrial cell lines. Method Enzymol. 264:484-509. https://doi.org/10.1016/S0076-6879(96)64044-0
  36. Wallace DC. 1992. Diseases of the mitochondrial DNA. Annu. Rev. Biochem. 61:1175-1212. https://doi.org/10.1146/annurev.bi.61.070192.005523
  37. Wu N and Ataai MM. 2000. Production of viral vectors for gene therapy applications. Curf. Opin. Biotechnol. 11 :205- 208. https://doi.org/10.1016/S0958-1669(00)00080-X
  38. Yagi T. 1993. The bacterial energy-transducing NADH-quinone oxidoreductases. Biochim. Biophys. Acta. 1141:1-17. https://doi.org/10.1016/0005-2728(93)90182-F
  39. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ and Muzyczka N. 1999. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6:973-985. https://doi.org/10.1038/sj.gt.3300938